Lakefront Biotherapeutics | GLPG - أصول متداولة





أصول متداولة تغيير تاريخ
argenx SE USD 6.9B 1.07B 2025-12
AstraZeneca USD 29.61B 890M 2026-03
Biogen USD 9.19B 216.3M 2026-03
Genmab DKK 2.88B 1.59B 2025-12
Gilead Sciences USD 18.64B 1.25B 2026-03
GlaxoSmithKline GBP 17.76B 251M 2026-03
GRIFOLS EUR 5.25B 180M 2026-03
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Incyte USD 5.48B 460.36M 2026-03
Merck EUR 14.16B 932M 2026-03
Neurocrine Biosciences USD 2.44B 86.6M 2026-03
Novartis USD 26.61B 3.85B 2026-03
Roche Holding CHF 38.73B 3.03B 2025-12
Sanofi EUR 30.16B 789M 2026-03
UCB EUR 6.05B 733M 2025-12
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03